• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Fortune 500
    • Fortune 500
    • Fortune Sea 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place To Work
  • Tech
    • Tech
    • Ai
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-suite
    • Ceo Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Maria Cheng

Stay informed with Maria Cheng’s coverage and analysis for Fortune.

  • Winnie Byanyima, Executive Director of the Joint United Nations Programme on HIV/AIDS UNAIDS, speaks during a conference in Dar es Salaam, Tanzania, on Nov. 29, 2022. TO GO WITH “UNAIDS report says inequalities undermining AIDS response” (Photo by Herman Emmanuel/Xinhua via Getty Images)Health

    HIV infections could surge if U.S. support is dropped and not replaced, UNAIDS chief says

    By Maria Cheng and The Associated Press
  • GERMANY, BONN – JULY 25: The photo illustration shows a medical syringe and an AIDS ribbon in the background on July 25, 2024 in Bonn, Germany. For 40 years, AIDS research has been searching for a vaccine in vain. Lenacapavir, which has been used in HIV therapy to date, is said to provide 100 percent protection abainst HIV infection. However, study results are still lacking. (Photo by Ulrich Baumgarten via Getty Images)Health

    A twice-yearly shot of this drug could help end AIDS — ‘it’s unprecedented’

    By Maria Cheng, María Verza, and others
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.